We confirmed and quantified their expression on the ovarian and melanoma cell lines by immunofluorescence using anti-CD112 and anti-CD155 specific monoclonal antibody based flow cytometry and each of our ovarian and melanoma tumour cell lines express both CD112 and CD155 (S4 Fig). This evidence concerns the gene PVR and neoplasm.